254 related articles for article (PubMed ID: 31975647)
21. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.
Birnbaum DJ; Gaujoux S; Cherif R; Dokmak S; Fuks D; Couvelard A; Vullierme MP; Ronot M; Ruszniewski P; Belghiti J; Sauvanet A
Surgery; 2014 Jan; 155(1):13-21. PubMed ID: 24238123
[TBL] [Abstract][Full Text] [Related]
22. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis.
Sallinen V; Le Large TY; Galeev S; Kovalenko Z; Tieftrunk E; Araujo R; Ceyhan GO; Gaujoux S
HPB (Oxford); 2017 Apr; 19(4):310-320. PubMed ID: 28254159
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY; Gong YF; Zhuang HK; Zhou ZX; Huang SZ; Zou YP; Huang BW; Sun ZH; Zhang CZ; Tang YQ; Hou BH
World J Gastroenterol; 2020 May; 26(19):2305-2322. PubMed ID: 32476795
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic neuroendocrine tumors.
Batcher E; Madaj P; Gianoukakis AG
Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
[TBL] [Abstract][Full Text] [Related]
26. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
[TBL] [Abstract][Full Text] [Related]
27. Surgical Management of Pancreatic Neuroendocrine Tumors.
Chiruvella A; Kooby DA
Surg Oncol Clin N Am; 2016 Apr; 25(2):401-21. PubMed ID: 27013372
[TBL] [Abstract][Full Text] [Related]
28. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors.
Sagami R; Nishikiori H; Ikuyama S; Murakami K
World J Gastroenterol; 2017 Oct; 23(37):6911-6919. PubMed ID: 29085235
[TBL] [Abstract][Full Text] [Related]
29. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
[TBL] [Abstract][Full Text] [Related]
30. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
[TBL] [Abstract][Full Text] [Related]
31. PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target.
Gurung B; Hua X; Runske M; Bennett B; LiVolsi V; Roses R; Fraker DA; Metz DC
Cancer Biol Ther; 2015; 16(2):219-24. PubMed ID: 25482929
[TBL] [Abstract][Full Text] [Related]
32. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
[TBL] [Abstract][Full Text] [Related]
33. Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.
Singh S; Dey C; Kennecke H; Kocha W; Maroun J; Metrakos P; Mukhtar T; Pasieka J; Rayson D; Rowsell C; Sideris L; Wong R; Law C
Ann Surg Oncol; 2015 Aug; 22(8):2685-99. PubMed ID: 25366583
[TBL] [Abstract][Full Text] [Related]
34. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
35. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
Parbhu SK; Adler DG
Hosp Pract (1995); 2016 Aug; 44(3):109-19. PubMed ID: 27404266
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine tumors of the pancreas.
Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
[TBL] [Abstract][Full Text] [Related]
38. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.
Lee LC; Grant CS; Salomao DR; Fletcher JG; Takahashi N; Fidler JL; Levy MJ; Huebner M
Surgery; 2012 Dec; 152(6):965-74. PubMed ID: 23102679
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumors of the pancreas.
Milan SA; Yeo CJ
Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
[TBL] [Abstract][Full Text] [Related]
40. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
